MRI features of combined hepatocellular-cholangiocarcinoma

被引:0
|
作者
Majeed, Noor Fatima [1 ]
Macey, Mathew [2 ]
Amirfarzan, Marta Braschi [3 ]
Sharifi, Sheida [2 ]
Wortman, Jeremy R. [2 ]
机构
[1] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30307 USA
[2] Lahey Hosp & Med Ctr, Dept Radiol, Burlington, MA USA
[3] Lahey Hosp & Med Ctr, Dept Pathol, Burlington, MA USA
关键词
Combined hepatocellular cholangiocarcinoma; Mixed hepatocellular cholangiocarcinoma; Cholangiohepatoma; Hepatocholangiocarcinoma; CARCINOMA;
D O I
10.1007/s00261-024-04476-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare liver tumor which has a more aggressive behavior and worse survival outcome than hepatocellular carcinoma (HCC), with a prognosis similar to that of intrahepatic cholangiocarcinoma (iCCA). With limited literature on the appearance of this tumor on MRI, it remains a diagnostic challenge. In this review, we looked at the currently described MRI findings in this uncommon entity. Based on studies conducted to date, a mixed pattern at imaging has demonstrated the highest specificity, seen as a combination of areas showing progressive enhancement of the lesion, arterial enhancement with washout, and areas of arterial enhancement without washout and/or hypovascularity. Tumor markers may aid in identification, particularly in cases where the imaging appearance mimics that of isolated HCC or iCCA. Intratumoral heterogeneity leads to difficulties with pathologic diagnosis from sampling due to the possibility of an incorrect diagnosis if the biopsy specimen does not contain adequate tissue comprising both histologic components.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 50 条
  • [41] Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management
    Ye, Liangtao
    Schneider, Julia S. S.
    Ben Khaled, Najib
    Schirmacher, Peter
    Seifert, Carolin
    Frey, Lea
    He, Yulong
    Geier, Andreas
    De Toni, Enrico N. N.
    Zhang, Changhua
    Reiter, Florian P. P.
    LIVER CANCER, 2024, 13 (01) : 6 - 28
  • [42] Breast Metastasis From a Combined Hepatocellular-Cholangiocarcinoma
    Silva, Marco
    Coelho, Rosa
    Rios, Elisabete
    Gomes, Sara
    Carneiro, Fatima
    Macedo, Guilherme
    ACG CASE REPORTS JOURNAL, 2019, 6 (04)
  • [43] Co-occurrence of hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma
    Suren, D.
    Yildirim, M.
    INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 622 - +
  • [44] Cytologic features of fibrolamellar carcinoma with mucin production: A rare variant of combined hepatocellular-cholangiocarcinoma
    Rosa, Marilin
    Mohammadi, Amir
    DIAGNOSTIC CYTOPATHOLOGY, 2014, 42 (05) : 431 - 435
  • [45] Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection
    Song, Peipei
    Midorikawa, Yutaka
    Nakayama, Hisashi
    Higaki, Tokio
    Moriguchi, Masamichi
    Aramaki, Osamu
    Yamazaki, Shintaro
    Aoki, Masaru
    Teramoto, Kenichi
    Takayama, Tadatoshi
    CANCER MEDICINE, 2019, 8 (13): : 5862 - 5871
  • [46] Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change Case report and literature review
    Gu, Qianru
    Yu, Xia
    Chen, Hanbin
    Chen, Guorong
    MEDICINE, 2018, 97 (03)
  • [47] Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma
    Granata, Vincenza
    Fusco, Roberta
    Setola, Sergio Venanzio
    Sandomenico, Fabio
    Barretta, Maria Luisa
    Belli, Andrea
    Palaia, Raffaele
    Tatangelo, Fabiana
    Grassi, Roberta
    Izzo, Francesco
    Petrillo, Antonella
    RADIOLOGY AND ONCOLOGY, 2020, 54 (02) : 149 - 158
  • [48] Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
    Calderaro, Julien
    Di Tommaso, Luca
    Maille, Pascale
    Beaufrere, Aurelie
    Nguyen, Cong Trung
    Heij, Lara
    Gnemmi, Viviane
    Graham, Rondell P.
    Charlotte, Frederic
    Chartier, Suzanne
    Wendum, Dominique
    Vij, Mukul
    Allende, Daniela
    Diaz, Alba
    Fuster, Carla
    Riviere, Benjamin
    Herrero, Astrid
    Augustin, Jeremy
    Evert, Katja
    Calvisi, Diego Francesco
    Leow, Wei Qiang
    Leung, Howard Ho Wai
    Bednarsch, Jan
    Boleslawski, Emmanuel
    Rela, Mohamed
    Chan, Anthony Wing-Hung
    Forner, Alejandro
    Reig, Maria
    Pujals, Anais
    Favre, Loetitia
    Allaire, Manon
    Scatton, Olivier
    Uguen, Arnaud
    Trepo, Eric
    Sanchez, Lukas Otero
    Chatelain, Denis
    Remmelink, Myriam
    Boulagnon-Rombi, Camille
    Bazille, Celine
    Sturm, Nathalie
    Menahem, Benjamin
    Frouin, Eric
    Tougeron, David
    Tournigand, Christophe
    Kempf, Emmanuelle
    Kim, Haeryoung
    Ningarhari, Massih
    Michalak-Provost, Sophie
    Kather, Jakob Nikolas
    Gouw, Annette S. H.
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1586 - 1597
  • [49] Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
    Auer, Timo Alexander
    Collettini, Federico
    Segger, Laura
    Pelzer, Uwe
    Mohr, Raphael
    Krenzien, Felix
    Gebauer, Bernhard
    Geisel, Dominik
    Hosse, Clarissa
    Schoening, Wenzel
    Fehrenbach, Uli
    CANCERS, 2023, 15 (09)
  • [50] Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma
    Kim, Dong Hwan
    Choi, Sang Hyun
    Kim, Dong Wook
    Lee, Seung Soo
    Lim, Young-Suk
    Kim, So Yeon
    Kim, Hyoung Jung
    Kim, Jin Hee
    Byun, Jae Ho
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 53 (06) : 1803 - 1812